Sec Form 3 Filing - Mehta Hardik @ Quipt Home Medical Corp. - 2024-10-01

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Mehta Hardik 2. Issuer Name and Ticker or Trading Symbol Quipt Home Medical Corp. [ QIPT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Financial Officer (Last) (First) (Middle) C/O QUIPT HOME MEDICAL CORP., 1019 TOWN DRIVE 3. Date of Earliest Transaction (MM/DD/YY) 10/01/2024 (Street) WILDER, KY41076 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Shares 791,699 I By Trust ( 1 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (right to buy) $ 6.27 ( 2 ) ( 2 ) 05/20/2031 Common Shares 60,000 D Restricted Share Units ( 3 ) ( 3 ) ( 3 ) Common Shares 115,624 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Mehta Hardik C/O QUIPT HOME MEDICAL CORP. 1019 TOWN DRIVE WILDER, KY41076 Chief Financial Officer Signatures /s/ Hardik Mehta 10/01/2024 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Shares are held by the SK Family Trust for the benefit of Mr. Mehta's children. Mr. Mehta disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Mr. Mehta is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. ( 2 )The exercise price for this award is denominated in Canadian dollars at 8.48. All these options have vested according to the award agreement and are, as of October 1, 2024, exercisable. Converted from Canadian dollars to United States dollars as of the date hereof at a conversion rate of 0.74 United States dollars per Canadian dollar. ( 3 )Each restricted share unit ("RSU") is the economic equivalent of one Common Share. Vested RSUs shall be settled in Common Shares. The RSUs shall vest in equal amounts as follows: February 20, 2024, May 20, 2024, August 20, 2024, November 20, 2024, and February 20, 2025.

Remarks: Quipt Home Medical Corp. (the "Issuer") has determined that it ceased to be a "foreign private issuer" as of March 31, 2024. As a result, effective October 1, 2024, the Issuer is required to comply with the reporting requirements and use the filing forms applicable to U.S. public companies under U.S. securities laws, including reports required under Section 16 of the U.S. Securities Exchange Act of 1934.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.